期刊文献+

新型冠状病毒肺炎的病原学特征及其抗病毒药物治疗进展 被引量:1

Progress in Etiology of COVID-19 and Medications with Antiviral Drugs against SARS-CoV-2
下载PDF
导出
摘要 新型冠状病毒肺炎(COVID-19)是由新冠病毒(SARS-CoV-2)引起的急性呼吸道传染病,人群波及广,严重破坏社会的生产力,是近百年来人类遭遇的影响范围最广的全球性大流行病,经济的全球化造成了全球疫情的大爆发。新冠病毒主要以飞沫形式传播,所以戴口罩和保持社交距离对疫情防控非常重要。随着新冠病毒疫苗的全面接种和口服抗新冠病毒药的开发,加上新冠病毒肺炎的流感化,全球的新冠病毒肺炎疫情控制指日可待。 COVID-19,which broke out in December 2019,is caused by severe acute respiratory syndrome coronavirus-2(SARS-CoV-2)infection.This epidemic has nearly overwhelmed the health care system in some countries.As two important physical means to block viral infections,wearing masks and social distancing can help contain the spread of pathogens through droplets.Along with global vaccination and development of oral antiviral drugs,the COVID-19 epidemic can be controlled in the near future.
作者 田野 凌云 龚伟玲 郭宇姝 TIAN Ye;LING Yun;GONG Wei-ling;GUO Yu-shu(Taipinglu Outpatient Department,Southern Medical District of Chinese PLA General Hospital,Beijing 100850,China;Hebei Yanda Hospital,Sanhc 065021.China;Administration for Drug and Instrument Supervision and Inspection of PLAJLSF,Beijing 100166,China;Medical Supplies Center of Chinese PLA General Hospital,Beijing 100048,China)
出处 《解放军药学学报》 CAS 2022年第1期45-49,共5页 Pharmaceutical Journal of Chinese People's Liberation Army
关键词 新冠病毒肺炎 新冠病毒 病原学 抗病毒药 Coronavirus disease 2019 SARS-CoV-2 etiology antiviral drugs
  • 相关文献

参考文献14

二级参考文献39

共引文献937

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部